-
FDA issues EUA to convalescent plasma for COVID–19 treatment
expresspharma
August 25, 2020
The FDA determined that it is reasonable to believe that COVID-19 convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some hospitalised patients.
-
FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment
worldpharmanews
August 24, 2020
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency's ongoing efforts to fight COVID-19.
-
As Convalescent Plasma is Authorized for Use as a Treatment Against COVID-19 in the US and China, Blood Banks Call for Donations
prnewswire
June 23, 2020
ResearchAndMarkets.com has published a new article on the blood banks industry "Blood Banks Call for Donations of Convalescent Plasma to Fight COVID-19".
-
Mayo finds convalescent plasma safe for diverse patients with COVID-19
worldpharmanews
June 22, 2020
Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients.
-
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
worldpharmanews
June 08, 2020
The country's first convalescent plasma transfusion trial results have been peer-reviewed and published, showing 19 out of 25 patients improving with the treatment and 11 discharged from the hospital.
-
Convalescent Plasma Trial Begins as Potential Treatment for COVID-19
americanpharmaceuticalreview
May 05, 2020
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma, taken from people who have recovered from COVID-19, is effective in treating the disease.
-
COVID-19 convalescent plasma therapy shows promise in pilot study
europeanpharmaceuticalreview
April 08, 2020
A pilot trial of convalescent plasma therapy in 10 severe COVID-19 patients has shown it may be a safe and promising therapeutic option.